Where do we go from here Gottfried Hirnschall
- Slides: 7
Where do we go from here? Gottfried Hirnschall Director HIV dept, WHO Monday, 23 July, 10: 15 -12: 15 Hall 11 B, RAI Amsterdam Slide 1 www. gap-f. org
In Summary… • Children are still getting infected and still not getting the best drugs in the formulations they need. • We need acceleration and we can’t do business as usual • There is a solid ground to build on – existing platforms and enthusiastic donors in drug optimization • GAP-f depends on strong partnerships with industry • Need for concrete action – joined forces – and accountability Slide 2 www. iasociety. org
WHO’s commitment • WHO R&D roadmap launched at WHA • Convene and lead GAP-f - critical partnerships required • GAP-f holds potential for broader pediatric drug needs contributing to reaching UHC • GAP-f capitalizes on scientific, global health and business experience • GAP-f to contribute to health care equity for all children around the world – leaving no-one behind! Slide 3 www. iasociety. org
Next Steps • Develop a business plan – draft end 2018 • Assess potential of the GAP-f initiative to other disease areas • Proactively follow up with industry partners on existing plans and commitments • Stay connected and give us your feedback! Slide 4 www. iasociety. org
Toolkit for research and development of paediatric antiretroviral drugs and formulations In collaboration with experts from the Paediatric Antiretroviral Working Group Available at http: //www. who. int/hiv/pub/research-dev-toolkit-paediatric-arv-drug-formulation/en/ https: //globalhealthtrainingcentre. tghn. org/research-toolkit-paediatric-antiretroviral-drug-and-formulation-development/
The AIDS Free Working Group Is pleased to announce the launch of a new AIDS FREE TOOLKIT FOR THE ACCELERATION OF TESTING AND TREATMENT SCALE-UP IN CHILDREN AND ADOLESCENTS LIVING WITH HIV Available at: http: //www. who. int/hiv/pub/paediatric/aids-free-toolkit/en/
Key publications available at www. gap-f. org Articles in The Lancet HIV and JIAS Slide 7 Supplements in JAIDS and JIAS www. iasociety. org
